home / stock / bvs / bvs news

BVS News and Press, Bioventus Inc. From 01/12/24

Stock Information
Company Name: Bioventus Inc.
Stock Symbol: BVS
Market: NASDAQ
Menu
BVS BVS Quote BVS Short BVS News BVS Articles BVS Message Board
Get BVS Alerts

News, Short Squeeze, Breakout and More Instantly...
BVS - Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole

DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, announced today the issuance on January 11, 2024 of previously disclosed inducement equity awards to Robe...
BVS - EXTR, URBN and APPI are among after hour movers

2024-01-09 16:20:04 ET Gainers: WISeKey International  ( WKEY ) +14% . MaxCyte ( MXCT ) +8% . Humacyte. ( HUMA ) +8% . Agora ( API ) +6% . Urban Outfitters ( URBN ) +6% . Losers: Grifols ( GRFS ) -9% . Ex...

BVS - Bioventus appoints Robert Claypoole as president and CEO

2023-12-19 16:40:11 ET More on Bioventus Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript Bioventus Inc. 2023 Q3 - Results - Earnings Call Presentation Bioventus Stock: Improving Outlook Keeps It Interesting Seeking Alpha’s Quant Rating on Biovent...

BVS - Bioventus Names Robert Claypoole as President and Chief Executive Officer

DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’...
BVS - Bioventus Agrees to Nationwide Contract with Aetna(TM) Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

DURHAM, N.C., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1,...

BVS - Bioventus Inc. (BVS) Q3 2023 Earnings Call Transcript

2023-11-12 00:55:22 ET Bioventus Inc. (BVS) Q3 2023 Earnings Conference Call November 7, 2023 08:30 ET Company Participants Dave Crawford - Vice President, Investor Relations Tony Bihl - Chief Executive Officer Mark Singleton - Senior Vice President and Chief Fin...

BVS - Bioventus Non-GAAP EPS of $0.05 beats by $0.07, revenue of $120.8M beats by $1.8M

2023-11-07 07:42:50 ET More on Bioventus Bioventus Stock: Improving Outlook Keeps It Interesting Bioventus Inc. (BVS) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Bioventus Historical earnings data for Bioventus Financial in...
BVS - Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance

DURHAM, N.C., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported financial results for the three and nine months ended September 30, 2023. Q3 Financial Summary: N...

BVS - Expected US Company Earnings on Tuesday, November 7th, 2023

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

BVS - Expected earnings - Bioventus Inc.

Bioventus Inc. (BVS) is expected to report $0.06 for Q3 2023
Previous 10 Next 10